Revofer 500 mg/10 ml (IV Injection or Infusion)

10 ml vial: ৳ 700.00

Medicine Details

Stepwise approach
Determination of individual iron need based on body weight and haemoglobin (Hb) level
Calculation and administration of the iron dose(s)
Post-iron repletion assessments
Maximum individual iron dose(s) based on iron need
Administration by intravenous injection or infusion
Re-assessment by the clinician based on the individual patient's condition
Re-assessment of Hb level no earlier than 4 weeks post final administration

Infrequent, usually mild and generally do not cause patients to stop treatment
Common: nausea, headache, dizziness, hypertension, injection site reactions
Uncommon: hypersensitivity, tachycardia, hypotension, flushing, dyspnoea, abdominal pain, constipation, diarrhea, Pruritus, urticaria, rash, myalgia, back pain, arthralgia, muscle spasms
Rare: anaphylactoid reactions, loss of consciousness, anxiety, phlebitis, syncope, bronchospasm, flatulence, angioedema, pallor, and face oedema, rigors, malaise, influenza like illness

Serious hypersensitivity reactions reported
Monitoring for signs and symptoms of hypersensitivity during and after administration
Hypertension: transient elevations in systolic blood pressure
Laboratory Test Alterations: overestimation of serum iron and transferrin bound iron by also measuring the iron in Revofer

Single maximum daily injection dose of 200 mg iron not to be exceeded in haemodialysis-dependent chronic kidney disease patients
Not recommended in children under 14 years

Excessive dosages may lead to accumulation of iron in storage sites potentially leading to hemosiderosis
Monitoring of iron parameters such as serum ferritin and transferrin saturation may assist in recognizing iron accumulation